Cited by 590SARS-CoV-2 and COVID-19 ResearchRNA Research and Splicinginterferon and immune responses

The DOI matches its Crossref record; 96 of the 100 references it cites were found in a registry or an index.

SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to Suppress Host Defenses

Open access

Banerjee, Abhik K., Blanco, Mario R., Bruce, Emily A., Honson, Drew D., Chen, Linlin M., Chow, Amy, Bhat, Prashant, Ollikainen, Noah, Quinodoz, Sofia A., Loney, Colin, Thai, Jasmine, Miller, Zachary D., Lin, Aaron E., Schmidt, Madaline M., Stewart, Douglas G., Goldfarb, Daniel, De Lorenzo, Giuditta, Rihn, Suzannah J., Voorhees, Rebecca M., Botten, Jason W., Majumdar, Devdoot, Guttman, Mitchell·2020·Cell

DOI 10.1016/j.cell.2020.10.004PMC PMC7543886

Open this paper in CoChat — free account Open PDF

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a recently identified coronavirus that causes the respiratory disease known as coronavirus disease 2019 (COVID-19). Despite the urgent need, we still do not fully understand the molecular basis of SARS-CoV-2 pathogenesis. Here, we comprehensively define the interactions between SARS-CoV-2 proteins and human RNAs. NSP16 binds to the mRNA recognition domains of the U1 and U2 splicing RNAs and acts to suppress global mRNA splicing upon SARS-CoV-2 infection. NSP1 binds to 18S ribosomal RNA in the mRNA entry channel of the ribosome and leads to global inhibition of mRNA translation upon infection. Finally, NSP8 and NSP9 bind to the 7SL RNA in the signal recognition particle and interfere with protein trafficking to the cell membrane upon infection. Disruption of each of these essential cellular functions acts to suppress the interferon response to viral infection. Our results uncover a multipronged strategy utilized by SARS-CoV-2 to antagonize essential cellular processes to suppress host defenses.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.cell.2020.10.004

Cites

96 of 96 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Trimmomatic: a flexible trimmer for Illumina sequence data
Bolger, A. M., Lohse, M., & Usadel, B. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu170 · Cited by 65,548
Fast gapped-read alignment with Bowtie 2
Langmead, B., & Salzberg, S. L. (2012) · Nature Methods · doi:10.1038/nmeth.1923 · Cited by 56,400
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709
The Protein Data Bank
Berman, H. M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.235 · Cited by 40,196
The PyMOL Molecular Graphics System
DeLano, W. L. (2002) · Medical Entomology and Zoology · Cited by 18,147
Integrative genomics viewer
Robinson, J. T., Thorvaldsdóttir, H., Winckler, W., Guttman, M., Lander, E. S., Getz, G., & Mesirov, J. P. (2011) · Nature Biotechnology · doi:10.1038/nbt.1754 · Cited by 15,390
Self-citation
The Molecular Signatures Database Hallmark Gene Set Collection
Liberzon, A., Birger, C., Thorvaldsdóttir, H., Ghandi, M., Mesirov, J. P., & Tamayo, P. (2015) · Cell Systems · doi:10.1016/j.cels.2015.12.004 · Cited by 13,807
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
Alexopoulou, L., Holt, A. C., Medzhitov, R., & Flavell, R. A. (2001) · Nature · doi:10.1038/35099560 · Cited by 6,129
The proximal origin of SARS-CoV-2
Andersen, K. G., Rambaut, A., Lipkin, W. I., Holmes, E. C., & Garry, R. F. (2020) · Nature Medicine · doi:10.1038/s41591-020-0820-9 · Cited by 5,081
Comparative Protein Structure Modeling Using Modeller
Eswar, N., Webb, B., Martı́-Renom, M. A., Madhusudhan, M. S., Eramian, D., Shen, M., Pieper, U., & Šali, A. (2006) · Current Protocols in Bioinformatics · doi:10.1002/0471250953.bi0506s15 · Cited by 4,618

Flagged first, then by citations

Show all 100 references

4 of the 100 references couldn’t be matched to a known paper.

Sorted by citations

Items 201–300 of 590

The 5′-terminal stem–loop RNA element of SARS-CoV-2 features highly dynamic structural elements that are sensitive to differences in cellular pH
Toews, S., Wacker, A., Faison, E. M., Duchardt, E., Richter, C. P., Mathieu, D., Bottaro, S., Zhang, Q., & Schwalbe, H. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae477 · Cited by 17
Impaired innate antiviral defenses in COVID-19: Causes, consequences and therapeutic opportunities
Galani, I. E., & Andreakos, E. (2021) · Seminars in Immunology · doi:10.1016/j.smim.2021.101522 · Cited by 17
Endothelial dysfunction as the typical pathological state
Vlasova, T. I., Петрищев, Н. Н., & Vlasov, T. D. (2022) · Regional blood circulation and microcirculation · doi:10.24884/1682-6655-2022-21-2-4-15 · Cited by 21
A signal recognition particle-related joint model of LASSO regression, SVM-RFE and artificial neural network for the diagnosis of systemic sclerosis-associated pulmonary hypertension
Xu, J., Liang, C., & Li, J. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.1078200 · Cited by 17
Identification of the viral and cellular microRNA interactomes during SARS-CoV-2 infection
Fossat, N., Lundsgaard, E. A., Costa, R., Rivera-Rangel, L. R., Nielsen, L., Mikkelsen, L. S., Ramírez, S., Bukh, J., & Scheel, T. K. H. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112282 · Cited by 17
Construction and characterization of two SARS‐CoV‐2 minigenome replicon systems
Zhang, H., Fischer, D. K., Shuda, M., Moore, P. S., Gao, S., Ambrose, Z., & Guo, H. (2022) · Journal of Medical Virology · doi:10.1002/jmv.27650 · Cited by 16
A systems biology approach identifies candidate drugs to reduce mortality in severely ill patients with COVID-19
Fava, V. M., Bourgey, M., Nawarathna, P. M., Orlova, M., Cassart, P., Vinh, D. C., Cheng, M. P., Bourque, G., Schurr, E., & Langlais, D. (2022) · Science Advances · doi:10.1126/sciadv.abm2510 · Cited by 16
Porcine epidemic diarrhea virus (PEDV) ORF3 protein inhibits cellular type I interferon signaling through down-regulating proteins expression in RLRs-mediated pathway
Zheng, L., Liu, H., Tian, Z., Kay, M., Wang, H., Cheng, L., Xia, W., Zhang, J., Wang, W., Cao, H., et al. (2023) · Research in Veterinary Science · doi:10.1016/j.rvsc.2023.03.022 · Cited by 16
Coronavirus takeover of host cell translation and intracellular antiviral response: a molecular perspective
Karousis, E. D., Schubert, K., & Ban, N. (2024) · The EMBO Journal · doi:10.1038/s44318-023-00019-8 · Cited by 16
Know your enemy and know yourself – the case of SARS-CoV-2 host factors
Lee, W. S., Yousefi, M., Yan, B., Yong, C. L., & Ooi, Y. S. (2021) · Current Opinion in Virology · doi:10.1016/j.coviro.2021.08.007 · Cited by 16
Innate Immunity Evasion Strategies of Highly Pathogenic Coronaviruses: SARS-CoV, MERS-CoV, and SARS-CoV-2
Li, J., Zhou, Z., Wang, Q., He, Q., Zhao, M., Qiu, Y., & Ge, X. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.770656 · Cited by 17
Executable network of SARS-CoV-2-host interaction predicts drug combination treatments
Howell, R. S. M., Clarke, M. A., Reuschl, A., Chen, T., Abbott-Imboden, S., Singer, M., Lowe, D. M., Bennett, C. L., Chain, B., Jolly, C. L., et al. (2022) · npj Digital Medicine · doi:10.1038/s41746-022-00561-5 · Cited by 17
In vivo inhibition of nuclear ACE2 translocation protects against SARS-CoV-2 replication and lung damage through epigenetic imprinting
Tu, W. J., Melino, M., Dunn, J., McCuaig, R., Bielefeldt‐Ohmann, H., Tsimbalyuk, S., Forwood, J. K., Ahuja, T., Vandermeide, J., Tan, X., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-39341-4 · Cited by 16
The translational landscape of SARS-CoV-2 and infected cellsPreprint
Puray‐Chavez, M., Lee, N., Tenneti, K., Wang, Y., Vuong, H. R., Liu, Y., Horani, A., Huang, T., Gunsten, S. P., Case, J. B., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.11.03.367516 · Cited by 16
Coronavirus endoribonuclease nsp15 suppresses host protein synthesis and evades PKR-eIF2α-mediated translation shutoff to ensure viral protein synthesis
Gong, X., Feng, S.-H., Wang, J.-H., Gao, B., Xue, W.-X., Chu, H.-Y., Fang, S., Yuan, Y.-M., Cheng, Y.-Q., Liao, M., et al. (2025) · PLoS Pathogens · doi:10.1371/journal.ppat.1012987 · Cited by 12
SARS-CoV-2 N protein potentiates host NPM1-snoRNA translation machinery to enhance viral replication
Wang, H., Shi, D., Jiang, P., Yu, Z., Han, Y., Zhang, Z., Wang, P., Huang, H., Yao, H., & Qian, P. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01210-9 · Cited by 15
Modulation of HERV Expression by Four Different Encephalitic Arboviruses during Infection of Human Primary Astrocytes
de Castro, F. L., Brustolini, O. J. B., Geddes, V. E. V., de Souza, J. M., Alves‐Leon, S. V., Aguiar, R. S., & de Vasconcelos, A. T. R. (2022) · Viruses · doi:10.3390/v14112505 · Cited by 14
Methotrexate inhibition of SARS-CoV-2 entry, infection and inflammation revealed by bioinformatics approach and a hamster model
Chen, Y., Chang, Y.-H., Pathak, N., Tzou, S.-C., Luo, Y.-C., Hsu, Y.-C., Li, T., Lee, J.-Y., Chen, Y.-C., Huang, Y., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1080897 · Cited by 15
SARS-CoV-2 targets ribosomal RNA biogenesis
Yerlici, V. T., Astori, A., Kejiou, N. S., Jordan, C. A., Khosraviani, N., Chan, J. N. Y., Hakem, R., Raught, B., Palazzo, A. F., & Mekhail, K. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.113891 · Cited by 16
Reduced A-to-I editing of endogenous Alu RNAs in lung after SARS-CoV-2 infection
Crooke, P. S., Tossberg, J. T., Porter, K. P., & Aune, T. M. (2021) · Current Research in Immunology · doi:10.1016/j.crimmu.2021.04.001 · Cited by 15
Mechanism of Inhibition of the Reproduction of SARS-CoV-2 and Ebola Viruses by Remdesivir
Wang, J., Reiss, K. M., Shi, Y., Lolis, E., Lisi, G. P., & Batista, V. S. (2021) · Biochemistry · doi:10.1021/acs.biochem.1c00292 · Cited by 17
An Immunoinformatics Approach for SARS-CoV-2 in Latam Populations and Multi-Epitope Vaccine Candidate Directed towards the World’s Population
Orduz, A. F. C., Díaz, L. L., Acosta, A. F., Peñaloza, M. K., Méndez, Y. R., Clavijo-Buriticá, D. C., & Yosa, J. (2021) · Vaccines · doi:10.3390/vaccines9060581 · Cited by 16
Human models for COVID‐19 research
Woodall, M. N. J., Masonou, T., Case, K., & Smith, C. M. (2021) · The Journal of Physiology · doi:10.1113/jp281499 · Cited by 13
Effect of cannabidiol on apoptosis and cellular interferon and interferon-stimulated gene responses to the SARS-CoV-2 genes ORF8, ORF10 and M protein
Fernandes, M. F., Chan, J. Z., Hung, C. C. J., Tomczewski, M. V., & Duncan, R. E. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120624 · Cited by 15
SARS-CoV-2 innate immune recognition and implications for respiratory health
Anang, V., Kumar, P., Pracha, J., Nho, R. S., Mora, A. L., Rojas, M. M., Gowdy, K. M., Yount, J. S., Bednash, J. S., Horowitz, J. C., et al. (2025) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2025.10.008 · Cited by 15
Angiotensin-converting enzyme 2 in peripheral lung club cells modulates the susceptibility to SARS-CoV-2 in chronic obstructive pulmonary disease
Peng, Y., Wang, Z.-N., Chen, S.-Y., Xu, A.-R., Fang, Z., Sun, J., Zhou, Z., Hou, X., Cen, L., Ma, J., et al. (2022) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00305.2021 · Cited by 14
Lessons Learned and Yet-to-Be Learned on the Importance of RNA Structure in SARS-CoV-2 Replication
Bassett, M., Salemi, M., & Magalis, B. R. (2022) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00057-21 · Cited by 14
CFTR Inhibitors Display In Vitro Antiviral Activity against SARS-CoV-2
Lagni, A., Lotti, V., Diani, E., Rossini, G., Concia, E., Sorio, C., & Gibellini, D. (2023) · Cells · doi:10.3390/cells12050776 · Cited by 14
Interaction of SARS-CoV-2 with host cells and antibodies: experiment and simulation
Nguyen, H. V., Nguyen, H. L., Lan, P. D., Thai, N. Q., Sikora, M., & Li, M. S. (2023) · Chemical Society Reviews · doi:10.1039/d1cs01170g · Cited by 15
Modulation of endoplasmic reticulum stress response pathways by respiratory viruses
Macauslane, K., Pegg, C. L., Short, K., & Schulz, B. (2023) · Critical reviews in microbiology · doi:10.1080/1040841x.2023.2274840 · Cited by 13
Differences in syncytia formation by SARS-CoV-2 variants modify host chromatin accessibility and cellular senescence via TP53
Lee, J. D., Menasché, B. L., Mavrikaki, M., Uyemura, M. M., Hong, S. M., Kozlova, N. V., Wei, J., Alfajaro, M. M., Filler, R. B., Müller, A. M., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113478 · Cited by 17
SARS-CoV-2 Nsp1 cooperates with initiation factors EIF1 and 1A to selectively enhance translation of viral RNA
Aviner, R., Lidsky, P. V., Xiao, Y., Tassetto, M., Kim, D., Zhang, L., McAlpine, P. L., Elias, J. E., Frydman, J., & Andino, R. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1011535 · Cited by 25
Host factors of SARS-CoV-2 in infection, pathogenesis, and long-term effects
Zhang, Y., Chen, S., Tian, Y., & Fu, X. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1407261 · Cited by 16
Mutational Landscape and Interaction of SARS-CoV-2 with Host Cellular Components
Srivastava, M., Hall, D., Omoru, O. B., Gill, H. M., Smith, S., & Janga, S. C. (2021) · Microorganisms · doi:10.3390/microorganisms9091794 · Cited by 13
Insights into pandemic respiratory viruses: manipulation of the antiviral interferon response by SARS-CoV-2 and influenza A virus
Liu, G., & Gack, M. U. (2022) · Current Opinion in Immunology · doi:10.1016/j.coi.2022.102252 · Cited by 14
Prevention of ribosome collision-induced neuromuscular degeneration by SARS CoV-2–encoded Nsp1
Wang, X., Rimal, S., Tantray, I., Geng, J., Bhurtel, S., Khaket, T. P., Li, W., Han, Z., & Lu, B. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2202322119 · Cited by 14
COVID-19 Biogenesis and Intracellular Transport
Aa, M., Savin, M. A., & Beznoussenko, G. V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054523 · Cited by 14
Unveiling the role of PUS7-mediated pseudouridylation in host protein interactions specific for the SARS-CoV-2 RNA genome
Giambruno, R., Zacco, E., Ugolini, C., Vandelli, A., Mulroney, L., D’Onghia, M., Giuliani, B., Criscuolo, E., Castelli, M., Clementi, N., et al. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.102052 · Cited by 14
KDELC1 and TRMT1 Serve as Prognosis-Related SARS-CoV-2 Proteins Binding Human mRNAs and Promising Biomarkers in Clear Cell Renal Cell Carcinoma
Li, C.-X., Yao, Y., Long, D., & Lin, X. (2021) · International Journal of General Medicine · doi:10.2147/ijgm.s312416 · Cited by 12
The Evolutionary Dance between Innate Host Antiviral Pathways and SARS-CoV-2
Aliyari, S. R., Quanquin, N. M., Pernet, O., Zhang, S., Wang, L., & Cheng, G. (2022) · Pathogens · doi:10.3390/pathogens11050538 · Cited by 17
Comprehensive mapping of SARS-CoV-2 interactions in vivo reveals functional virus-host interactionsPreprint
Yang, S. L., DeFalco, L., Anderson, D. E., Zhang, Y., Aw, A. J., Lim, S. Y., Ni, L. X., Tan, K. Y., Zhang, T., Chawla, T., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.17.427000 · Cited by 14
Global landscape of the host response to SARS-CoV-2 variants reveals viral evolutionary trajectoriesPreprint
Bouhaddou, M., Reuschl, A., Polacco, B. J., Thorne, L., Ummadi, M. R., Ye, C., Rosales, R., Pelin, A., Batra, J., Jang, G. Μ., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.10.19.512927 · Cited by 14
Pathogenesis and virulence of coronavirus disease: Comparative pathology of animal models for COVID-19
Kirk, N. M., Liang, Y., & Ly, H. (2024) · Virulence · doi:10.1080/21505594.2024.2316438 · Cited by 13
The art of hijacking: how Nsp1 impacts host gene expression during coronaviral infections
Karousis, E. (2024) · Biochemical Society Transactions · doi:10.1042/bst20231119 · Cited by 13
Host-like RNA Elements Regulate Virus Translation
Khan, D., & Fox, P. L. (2024) · Viruses · doi:10.3390/v16030468 · Cited by 14
Human coronaviruses: activation and antagonism of innate immune responses
Tanneti, N. S., Stillwell, H. A., & Weiss, S. R. (2024) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00016-23 · Cited by 14
Binding of a pyrimidine RNA base-mimic to SARS-CoV-2 nonstructural protein 9
Littler, D. R., Mohanty, B., Lowery, S. A., Colson, R. N., Gully, B. S., Perlman, S. M., Scanlon, M. J., & Rossjohn, J. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101018 · Cited by 13
Searching and Analyzing Patent-Relevant Information for Evaluating COVID-19 Innovation
Falciola, L., & Barbieri, M. (2020) · World Patent Information · doi:10.1016/j.wpi.2022.102094 · Cited by 15
Proteomic landscape of SARS-CoV-2– and MERS-CoV–infected primary human renal epithelial cells
Kohli, A., Sauerhering, L., Fehling, S. K., Klann, K., Geiger, H., Becker, S., Koch, B., Baer, P. C., Strecker, T., & Münch, C. (2022) · Life Science Alliance · doi:10.26508/lsa.202201371 · Cited by 13
Human phospho‐signaling networks of SARS‐CoV‐2 infection are rewired by population genetic variants
Pellegrina, D. V. D. S., Bahcheli, A. T., Krassowski, M., & Reimand, J. (2022) · Molecular Systems Biology · doi:10.15252/msb.202110823 · Cited by 11
COVID-19-specific transcriptomic signature detectable in blood across multiple cohorts
Välikangas, T., Junttila, S., Rytkönen, K. T., Kukkonen-Macchi, A., Suomi, T., & Elo, L. L. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.929887 · Cited by 12
A snapshot of protein trafficking in SARS‐CoV‐2 infection
Prasad, V. R., & Bartenschlager, R. F. W. (2022) · Biology of the Cell · doi:10.1111/boc.202200073 · Cited by 16
The Interplay Between Coronavirus and Type I IFN Response
Xue, W., Ding, C., Qian, K., & Liao, Y. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.805472 · Cited by 13
Severity of SARS-CoV-2 infection as a function of the interferon landscape across the respiratory tract of COVID-19 patientsPreprint
Sposito, B., Broggi, A., Pandolfi, L., Crotta, S., Ferrarese, R., Sisti, S., Clementi, N., Ambrosi, A., Liu, E., Frangipane, V., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.03.30.437173 · Cited by 13
Mechanisms of impairment of interferon production by SARS-CoV-2
Hoang, H., Naeli, P., Alain, T., & Jafarnejad, S. M. (2023) · Biochemical Society Transactions · doi:10.1042/bst20221037 · Cited by 12
High-sensitivity profiling of SARS-CoV-2 noncoding region–host protein interactome reveals the potential regulatory role of negative-sense viral RNA
Jiang, L., Xiao, M., Liao, Q., Zheng, L., Li, C., Liu, Y., Yang, B., Ren, A., Jiang, C., & Feng, X. (2023) · mSystems · doi:10.1128/msystems.00135-23 · Cited by 12
The respiratory syncytial virus M2-2 protein is targeted for proteasome degradation and inhibits translation and stress granules assembly
Scudero, O. B., Santiago, V. F., Palmisano, G., Simabuco, F. M., & Ventura, A. M. (2023) · PLoS ONE · doi:10.1371/journal.pone.0289100 · Cited by 12
Coronavirus 2′-O-methyltransferase: A promising therapeutic target
Schindewolf, C., & Menachery, V. D. (2023) · Virus Research · doi:10.1016/j.virusres.2023.199211 · Cited by 21
The comprehensive SARS-CoV-2 ‘hijackome’ knowledge base
Huuskonen, S., Liu, X., Pöhner, I., Redchuk, T., Salokas, K., Lundberg, R., Maljanen, S., Belik, M., Reinholm, A., Kolehmainen, P., et al. (2024) · Cell Discovery · doi:10.1038/s41421-024-00748-y · Cited by 12
The impact of Coronavirus Nsp1 on host mRNA degradation is independent of its role in translation inhibition
Bäumlin, E., Andenmatten, D., Luginbühl, J., Lalou, A., Schwaller, N., & Karousis, E. D. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115488 · Cited by 12
Analysis of RNA translation with a deep learning architecture provides new insight into translation control
(2025) · doi:10.1093/nar/gkaf277 · Cited by 12
Metabolomics Signatures of SARS-CoV-2 Infection
Arjmand, B., Alavi-Moghadam, S., Roudsari, P. P., Rezaei–Tavirani, M., Tayanloo-Beik, A., Goodarzi, P., Mehrdad, N., Mohamadi-Jahani, F., & Larijani, B. A. (2021) · Advances in experimental medicine and biology · doi:10.1007/5584_2021_674 · Cited by 12
A Structurally Conserved RNA Element within SARS-CoV-2 ORF1a RNA and S mRNA Regulates Translation in Response to Viral S Protein-Induced Signaling in Human Lung Cells
Basu, A., Penumutchu, S. R., Nguyen, K., Mbonye, U. R., Tolbert, B. S., Karn, J., Komar, A. A., & Mazumder, B. (2021) · Journal of Virology · doi:10.1128/jvi.01678-21 · Cited by 12
CLIP and complementary methods
(2021) · Nature Reviews Methods Primers · doi:10.1038/s43586-021-00023-4 · Cited by 15
All differential on the splicing front: Host alternative splicing alters the landscape of virus-host conflict
Mann, J. T., Riley, B. A., & Baker, S. F. (2023) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2023.01.013 · Cited by 14
Classification, replication, and transcription of Nidovirales
Liao, Y., Wang, H., Liao, H., Sun, Y., Tan, L., Song, C., Qiu, X., & Ding, C. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1291761 · Cited by 11
Differential beta‐coronavirus infection dynamics in human bronchial epithelial organoids
Park, D., Kim, S., Jang, H. B., Kim, K., Ji, H. Y., Yang, H., Kwon, W., Kang, Y.-L., Hwang, S., Kim, H., et al. (2024) · Journal of Medical Virology · doi:10.1002/jmv.29600 · Cited by 10
COVID-19: A threat to the respiratory system
Rasool, G., Khan, W. A., Khan, A., Riaz, M., Abbas, M., Rehman, A. U., Irshad, S., & Ahmad, S. (2024) · International Journal of Immunopathology and Pharmacology · doi:10.1177/03946320241310307 · Cited by 11
Impact of Ribosome Activity on SARS-CoV-2 LNP – Based mRNA Vaccines
Tsiambas, E., Chrysovergis, A., PAPANIKOLAOU, V. S., MASTRONIKOLIS, N. S., Ragos, V., Batistatou, A. K., Peschos, D., Kavantzas, N., Lazaris, A. C., & Kyrodimos, E. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.654866 · Cited by 11
Infection‐induced inflammation from specific inborn errors of immunity to COVID‐19
Ku, C., Chen, I., & Lai, M. (2021) · FEBS Journal · doi:10.1111/febs.15961 · Cited by 11
COVID-19 Salivary Protein Profile: Unravelling Molecular Aspects of SARS-CoV-2 Infection
Esteves, E., Mendes, V. M., Manadas, B. J., Lopes, R., Bernardino, L. I., Correia, M. J., Barros, M., Esteves, A. C., & Rosa, N. D. N. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11195571 · Cited by 11
SARS-CoV-2 viral protein Nsp2 stimulates translation under normal and hypoxic conditions
Korneeva, N. L., Khalil, M. I., Ghosh, I., Fan, R., Arnold, T., & Benedetti, A. D. (2023) · Virology Journal · doi:10.1186/s12985-023-02021-2 · Cited by 11
SARS-CoV-2: analysis of the effects of mutations in non-structural proteins
Senthilazhagan, K., Sakthimani, S., Kallanja, D., & Venkataraman, S. (2023) · Archives of Virology · doi:10.1007/s00705-023-05818-2 · Cited by 10
SARS-CoV-2 viral genes Nsp6, Nsp8, and M compromise cellular ATP levels to impair survival and function of human pluripotent stem cell-derived cardiomyocytes
Liu, J., Zhang, Y., Wu, S., Han, L., Wang, C., Liu, S., Simpson, E., Liu, Y., Wang, Y., Shou, W., et al. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03485-3 · Cited by 9
Brain Pathology in COVID-19: Clinical Manifestations and Potential Mechanisms
Xu, Z., Wang, H., Jiang, S., Teng, J., Zhou, D., Chen, Z., Wen, C., & Xu, Z. (2023) · Neuroscience Bulletin · doi:10.1007/s12264-023-01110-0 · Cited by 10
Insight into the emerging role of SARS-CoV-2 nonstructural and accessory proteins in modulation of multiple mechanisms of host innate defense
Abdalla, A. E., Xie, J., Junaid, K., Younas, S., Elsaman, T., Abosalif, K. O. A., Alameen, A. A. M., Mahjoob, M. O., Elamir, M. Y. M., & Ejaz, H. (2021) · Bosnian Journal of Basic Medical Sciences · doi:10.17305/bjbms.2020.5543 · Cited by 11
A highly sensitive NanoLuc-based protease biosensor for detecting apoptosis and SARS-CoV-2 infection
Arakawa, M., Yoshida, A., Okamura, S., Ebina, H., & Morita, E. (2023) · Scientific Reports · doi:10.1038/s41598-023-28984-4 · Cited by 10
Transcriptomic analysis of sorted lung cells revealed a proviral activity of the NF-κB pathway toward SARS-CoV-2
Bhargava, A., Szachnowski, U., Chazal, M., Foretek, D., Caval, V., Aicher, S., da Fonseca, J. P., Jeannin, P., Beauclair, G., Monot, M., et al. (2023) · iScience · doi:10.1016/j.isci.2023.108449 · Cited by 12
The differential effect of SARS-CoV-2 NSP1 on mRNA translation and stability reveals new insights linking ribosome recruitment, codon usage, and virus evolution
Berlanga, J. J., Matamoros, T., Rodríguez‐Pulido, M., Sáiz, M., Bayón, M. N., Toribio, R., & Ventoso, I. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf261 · Cited by 11
Proximity-dependent biotinylation detects associations between SARS coronavirus nonstructural protein 1 and stress granule–associated proteins
Gerassimovich, Y. A., Miladinovski-Bangall, S. J., Bridges, K. M., Boateng, L. K., Ball, L. E., Valafar, H., & Nag, A. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101399 · Cited by 10
Understanding Kids and COVID
Peeples, L. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2203753119 · Cited by 10
Roles of RNA Sensors in Host Innate Response to Influenza Virus and Coronavirus Infections
Li, W., Wang, H., & Zheng, S. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158285 · Cited by 10
RNA-dependent RNA polymerase of SARS-CoV-2 regulate host mRNA translation efficiency by hijacking eEF1A factors
Gan, H., Zhou, X., Lei, Q., Wu, L., Niu, J., & Zheng, Q. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166871 · Cited by 10
Intrinsic factors behind long COVID: IV. Hypothetical roles of the SARS‐CoV‐2 nucleocapsid protein and its liquid–liquid phase separation
Eltayeb, A., Al-Sarraj, F. M., Alharbi, M. G., Albiheyri, R. S., Mattar, E. H., Zeid, I. M. A., Bouback, T. A., Bamagoos, A. A., Uversky, V. N., Rubio‐Casillas, A., et al. (2024) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30530 · Cited by 11
COVID-19 therapies: do we see substantial progress?
Matusewicz, L., Golec, M., Czogalla, A., Kuliczkowski, K., Konka, A., Zembala-John, J., & Sikorski, A. F. (2022) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-022-00341-9 · Cited by 10
HERC5-mediated ISGylation of SARS-CoV-2 nsp8 facilitates its degradation and inhibits viral replication
Hou, Y., Shi, H., Wang, H., Tian, L., Chen, H., Liu, Y., Wang, H., & Zhang, W. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.144546 · Cited by 10
High-Content Screening and Computational Prediction Reveal Viral Genes That Suppress the Innate Immune Response
Ng, T. L., Olson, E. J., Yoo, T. Y., Weiss, H. S., Koide, Y., Koch, P. D., Rollins, N. J., Mach, P., Meisinger, T., Bricken, T., et al. (2022) · mSystems · doi:10.1128/msystems.01466-21 · Cited by 9
Pathogenic Mechanism and Multi-omics Analysis of Oral Manifestations in COVID-19
Hao, M., Wang, D., Xia, Q., Kan, S., Chang, L., Liu, H., Yang, Z., & Liu, W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.879792 · Cited by 11
SARS-COV-2 protein NSP9 promotes cytokine production by targeting TBK1
Zhang, Y., Xin, B., Liu, Y., Jiang, W., Han, W., Deng, J., Wang, P., Hong, X., & Yan, D. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1211816 · Cited by 9
Innate immunology in COVID-19—a living review. Part I: viral entry, sensing and evasion
Coveney, C. R., Tellier, M., Lu, F., Maleki-Toyserkani, S., Jones, R. E., Bart, V. M. T., Pring, E., Alrubayyi, A., Richter, F. C., Scourfield, D. O., et al. (2020) · Oxford Open Immunology · doi:10.1093/oxfimm/iqaa004 · Cited by 11
The severe acute respiratory syndrome coronavirus 2 non-structural proteins 1 and 15 proteins mediate antiviral immune evasion
Boodhoo, N., Matsuyama-Kato, A., Shojadoost, B., Behboudi, S., & Sharif, S. (2022) · Current Research in Virological Science · doi:10.1016/j.crviro.2022.100021 · Cited by 9
Implications of helminth immunomodulation on COVID-19 co-infections
Chacón, N., Chacín‐Bonilla, L., & Italo, M. (2021) · Life Research · doi:10.53388/life2021-0502-309 · Cited by 9
Integration and Reanalysis of Four RNA-Seq Datasets Including BALF, Nasopharyngeal Swabs, Lung Biopsy, and Mouse Models Reveals Common Immune Features of COVID-19
Alberts, R., Chan, S. C. L., Meng, Q., He, S., Rao, L., Liu, X., & Zhang, Y. (2022) · Immune Network · doi:10.4110/in.2022.22.e22 · Cited by 8
Nonstructural protein 1 widespread RNA decay phenotype varies among coronaviruses
Bermudez, Y., Miles, J., & Muller, M. (2022) · iScience · doi:10.1016/j.isci.2022.105887 · Cited by 9
The SARS-CoV-2 UTR’s Intrudes Host RBP’s and Modulates Cellular Splicing
Singh, A., Pandey, K. K., Agrawal, S. K., Srivastava, R. K., Bhattacharyya, S., & Verma, B. (2023) · Advances in Virology · doi:10.1155/2023/2995443 · Cited by 8
Extended ensemble simulations of a SARS-CoV-2 nsp1–5’-UTR complex
Sakuraba, S., Xie, Q., Kasahara, K., Iwakiri, J., & Kono, H. (2022) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1009804 · Cited by 9
Autoantibodies targeting cytokines and connective tissue disease autoantigens are common in acute non-SARS-CoV-2 infections.Preprint
Feng, A., Yang, E., Moore, A. R., Dhingra, S., Chang, S. E., Yin, X., Pi, R., Mack, E., Völkel, S., Gessner, R. V., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1233038/v1 · Cited by 9
SARS-CoV-2 Nsp1 regulates translation start site fidelity to promote infectionPreprint
Aviner, R., Lidsky, P. V., Xiao, Y., Tassetto, M., Zhang, L., McAlpine, P. L., Elias, J. E., Frydman, J., & Andino, R. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.07.05.547902 · Cited by 9
A knowledge-based protein-protein interaction inhibition (KPI) pipeline: an insight from drug repositioning for COVID-19 inhibition
Lanjanian, H., Hosseini, S., Narimani, Z., Meknatkhah, S., & Riazi, G. H. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2022.2163425 · Cited by 8
Optimization of 5′UTR to evade SARS-CoV-2 Nonstructural protein 1-directed inhibition of protein synthesis in cells
Chen, S.-C., Xu, C.-T., Chang, C.-F., Chao, T.-Y., Lin, C., Fu, P.-W., & Yu, C. (2023) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-023-12442-2 · Cited by 8

Authors: Banerjee, A. K., Blanco, M. R., Bruce, E. A., Honson, D. D., Chen, L. M., Chow, A., Bhat, P., Ollikainen, N., Quinodoz, S. A., Loney, C., Thai, J., Miller, Z. D., Lin, A. E., Schmidt, M. M., Stewart, D. G., Goldfarb, D., De Lorenzo, G., Rihn, S. J., Voorhees, R. M., Botten, J. W., Majumdar, D., & Guttman, M.
Affiliations: University of Southern California (US)
California Institute of Technology (US)
University of Vermont (US)
MRC University of Glasgow Centre for Virus Research (GB)
Broad Institute (US)
Corresponding author: Majumdar, Devdoot
Guttman, Mitchell
ORCID: Banerjee, Abhik K.
Blanco, Mario R.
Bruce, Emily A.
Honson, Drew D.
Chen, Linlin M.
Chow, Amy
Bhat, Prashant
Ollikainen, Noah
Quinodoz, Sofia A.
Loney, Colin
Miller, Zachary D.
Lin, Aaron E.
Schmidt, Madaline M.
Stewart, Douglas G.
Goldfarb, Daniel
De Lorenzo, Giuditta
Rihn, Suzannah J.
Voorhees, Rebecca M.
Botten, Jason W.
Majumdar, Devdoot
Guttman, Mitchell
Venue: Cell
Publisher: Elsevier BV
Published: 2020-11
Volume: 183
Issue: 5
Pages: 1325-1339.e21
ISSN: 0092-8674 (ISSN-L)
DOI: 10.1016/j.cell.2020.10.004
PMC: PMC7543886
OpenAlex: W3092296275
Cited by: 583
References: 100
Citations by year: 2026: 40 · 2025: 64 · 2024: 80 · 2023: 106 · 2022: 149 · 2021: 129 · 2020: 15
FWCI: 13.29
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
creativecommons.org/licenses/by/4.0/ (vor)
Locations: Cell (publishedVersion, cc-by)
PubMed Central (publishedVersion, cc-by)
PubMed (publishedVersion)
ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion, cc-by-sa)
CaltechAUTHORS (California Institute of Technology) (submittedVersion, cc-by)
Funders: Wellcome Trust
University of Vermont
Heritage Medical Research Institute
American Cancer Society
Foundation for the National Institutes of Health
Chan Zuckerberg Initiative
California Institute of Technology
New York Stem Cell Foundation
Topics: Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
Keywords: SARS-CoV-2, COVID-19 pandemic, host-virus interaction, nsp16, Nsp1, 18S rRNA, mRNA translation inhibition, nsp8, nsp9, 7SL RNA, signal recognition particle, protein trafficking, viral pathogenesis
MeSH terms: A549 Cells, COVID-19, SARS-CoV-2, Animals, Chlorocebus aethiops, Humans, Interferons, RNA Splicing, RNA, Messenger, RNA, Ribosomal, 18S, Protein Biosynthesis, Vero Cells, Viral Nonstructural Proteins, Signal Recognition Particle, RNA, Small Cytoplasmic, Protein Transport, Host-Pathogen Interactions, HEK293 Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to Suppress Host Defenses

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks